Last reviewed · How we verify
Colloid Volume Kinetics in Morbidly Obese Patients Under General Anaesthesia
There is no objective evidence of how long intravenous solutions remain inside venous blood vessels after they have been administered, therefore there is no definite guideline of how to administer them in the preoperative setting. Besides, obese patients represent a particular group of subjects as they theoretically with-hold a constant inflammatory response and that would modify the way solutions behave intravenously, that is how long they remain inside. Having said this, we wish to describe the way colloid solutions behave in this group of patients by taking serial blood samples in 12 obese patients after a colloid infusion, to calculate plasma dilution curves based on hemoglobin dilution and therefore infer the time it remains intravascularly. All this in the hope this information will help, in the near future, to establish a more objective way to use these solutions and avoid possible complications due to over-administration.
Details
| Lead sponsor | National Institute of Medical Sciences and Nutrition, Salvador Zubiran |
|---|---|
| Phase | NA |
| Status | UNKNOWN |
| Enrolment | 12 |
| Start date | 2012-05 |
| Completion | 2012-12 |
Conditions
- Obesity
- Obesity, Morbid
Interventions
- Tetrastarch (130/0.4)
Primary outcomes
- description of colloid volume kinetics in obese patients after the infusion of Tetrastarch (130/0.4) — 90 minutes after beginning of the infusion
different kinetic parameters will be used to asses the behavior of the colloid solution
Countries
Mexico